跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,287 条关于
“Choroidal Neovascularization”
全部
1,287
临床试验
1,155
药物
10
机构
1
资讯
121
去年
FDA-Approved Cimerli: First Interchangeable Biosimilar for Ocular Conditions Now Available
去年
First Comprehensive Post-Marketing Safety Comparison Reveals Differing Adverse Event Profiles for Geographic Atrophy Treatments
9个月前
Chugai's Vabysmo Demonstrates Sustained Vision Improvements in 48-Week Angioid Streaks Trial
去年
Chugai's Vabysmo Becomes First Approved Treatment for Angioid Streaks in Japan
12个月前
Alvotech Secures Japanese Approval for Three Biosimilars Including First Global Golimumab Biosimilar
2年前
Chugai Seeks Approval in Japan for Vabysmo to Treat Angioid Streaks
3个月前
Kexing Biopharm Doses First Subject in Phase I Trial of Bispecific Antibody GB10 for Neovascular AMD
去年
Individualized Treatment Strategies Key to Managing Geographic Atrophy
去年
FDA Sets October 2025 Decision Date for Xbrane's Ranibizumab Biosimilar Application
去年
Alkeus' Oral Gildeuretinol Shows Promise in Slowing Geographic Atrophy Progression
第 1 页，共 13 页
上一页
下一页
